Morning Overview on MSN
Scientists find a new way to slow aging inside cells
Scientists are no longer just cataloging the damage that comes with age, they are starting to rewire the machinery inside ...
Khaleej Times on MSN
UAE approves gene therapy for new age group in spinal muscular atrophy patients
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly ...
The story so far: The Nobel Prize season for 2025 began with the announcement of the Physiology or Medicine Prize on October 6. The three awardees — U.S.-based researchers, Mary E. Brunkow and Fred ...
The 2025 Nobel Prize in physiology or medicine has been awarded to a trio of scientists – two of them American and one Japanese – for unraveling how the immune system protects us from thousands of ...
A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study ...
The least-squares mean difference in the Hammersmith Functional Motor Scale-Expanded change from baseline at 12 months was 1.8 points for those 2 to 12 years receiving apitegromab vs placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback